Advocacy intelligence hub — real-time data for patient organizations
Picterus AS — NA
To decrease the need for red blood cell (RBC) transfusion due to hemolysis in adults with cold agglutinin disease (CAD)
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Enjaymo
(SUTIMLIMAB-JOME)Orphan drugRecordati Rare Diseases, Inc.
Classical Complement Pathway Inhibitor [EPC]
12.1 Mechanism of Action Sutimlimab-jome is an immunoglobulin G (IgG), subclass 4 (IgG4) monoclonal antibody (mAb) that inhibits the classical complem...
Paul Szabolcs, MD
UPMC Children's Hospital of Pittsburgh
📍 Pittsburgh, Pennsylvania
Kathleen Butler, MD
Incyte Corporation
Adela Cardones, MD, M.D
Duke University
📍 DURHAM, NC
Houman Hemmati, MD, M.D., Ph.D
Sanguine Biosciences
📍 LOS ANGELES, CA
David T. Teachey, MD, M.D
Children's Hospital of Philadelphia
📍 PHILADELPHIA, PA
Keith Sullivan, MD
Duke University